The Claim
Genetically predicted erythritol levels are associated with a small but consistent increase in the risk of cardiovascular events, with odds ratios ranging from 1.0015 to 1.0463 across multiple sensitivity analyses including weighted median, MR-Egger, and mode methods.
What the research says
Not yet evaluated
We are still looking at what the research says.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
People with genetically higher predicted levels of erythritol have a slightly higher risk of cardiovascular events, and this pattern holds across multiple statistical methods.
See the scientific wording
The association between genetically predicted erythritol levels and cardiovascular events is small (odds ratios between 1.0015 and 1.0463), but consistent across multiple sensitivity analyses including weighted median, MR-Egger, and mode methods, suggesting the signal is robust despite potential pleiotropy and weak instrument bias.
High levels of erythritol in the blood cause blood platelets to become overly active, making them stick together more easily and form clots inside blood vessels. These clots block arteries in the heart or brain, leading to heart attacks or strokes.
What the research says
1 studyThis study found that people with a genetic tendency to have more erythritol in their blood had a tiny but real increase in heart disease and stroke risk, and this link stayed the same no matter how scientists checked it—so it’s probably real, not a fluke.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.